pollastre
Madmaxista
- Desde
- 18 Ene 2010
- Mensajes
- 5.407
- Reputación
- 8.200
Clavado, caballero... 10,871.8 es lo que tengo.
Ahora bien, que lo quieran tocar o no... ya veremos.
¿Habéis visto el Ibex 35...? Septiembre 2010 +
- Autor del tema pecata minuta
- Fecha de inicio
Clavado, caballero... 10,871.8 es lo que tengo.
Ahora bien, que lo quieran tocar o no... ya veremos.
donpepito
Madmaxista
Kaplan Fox & Kilsheimer LLP (Welcome to Kaplan Fox) has filed a against Arena Pharmaceuticals, Inc. ("Arena" or the "Company") (NASDAQ: ARNA | PowerRating) that alleges abusations of the Securities Exchange Act of 1934 and the Securities Act of 1933 on behalf of purchasers of Arena during the period May 11, 2009 and September 16, 2010 inclusive, including investors who purchased Arena shares in the Company's public offerings of during the Class Period (the "Class").
The case is pending in the United States District Court for the Southern District of California. A copy of the complaint may be obtained from Kaplan Fox or the Court. The Complaint alleges that throughout the Class Period the Company represented to investors that the New Drug Application ("NDA") for its drug lorcaserin, or Lorqess, was based on extensive and robust data, and, that lorcaserin's combination of efficacy, safety and tolerability would position the drug candidate as first-line therapy for weight management.
The Complaint further alleges that on September 14, 2010, investors began to learn the truth about lorcaserin when the FDA disclosed a Briefinghttp://www.tradingmarkets.com/news/...f-arena-pharmaceuticals-inc-sec-1179920.html# titled NDA 22529 Lorqess (lorcaserin hydrochloride) Tablets, 10 mg Sponsor: Arena Pharmaceuticals Advisory Committee - September 16, 2010, which revealed, among other things, that lorcaserin caused cancer in rats in certain preclinical studies.
On September 14, 2010, Arena shares declined from a close on September 13, 2010 of $6.85 per share, to close at $4.13 per share, a decline of $2.71 per share or approximately 40%. On September 16, 2010, the Wall Street Journal reported a federal advisory panel rejected lorcaserin. On September 17, 2010, Arena shares declined an additional $1.99 per share or approximately 47%.
The case is pending in the United States District Court for the Southern District of California. A copy of the complaint may be obtained from Kaplan Fox or the Court. The Complaint alleges that throughout the Class Period the Company represented to investors that the New Drug Application ("NDA") for its drug lorcaserin, or Lorqess, was based on extensive and robust data, and, that lorcaserin's combination of efficacy, safety and tolerability would position the drug candidate as first-line therapy for weight management.
The Complaint further alleges that on September 14, 2010, investors began to learn the truth about lorcaserin when the FDA disclosed a Briefinghttp://www.tradingmarkets.com/news/...f-arena-pharmaceuticals-inc-sec-1179920.html# titled NDA 22529 Lorqess (lorcaserin hydrochloride) Tablets, 10 mg Sponsor: Arena Pharmaceuticals Advisory Committee - September 16, 2010, which revealed, among other things, that lorcaserin caused cancer in rats in certain preclinical studies.
On September 14, 2010, Arena shares declined from a close on September 13, 2010 of $6.85 per share, to close at $4.13 per share, a decline of $2.71 per share or approximately 40%. On September 16, 2010, the Wall Street Journal reported a federal advisory panel rejected lorcaserin. On September 17, 2010, Arena shares declined an additional $1.99 per share or approximately 47%.
Samzer
Madmaxista
- Desde
- 7 Ago 2008
- Mensajes
- 6.192
- Reputación
- 4.886
No se si ya conocíais el dato pero por si acaso (listado dentro del link):
Insider Selling Outpaces Buying By Over 290-To-1 In Past Week | zero hedge
According to Bloomberg, for the week ended September 17, corporate insiders bought $1.4MM in shares in a whopping 7 different companies. This was just marginally offset by sales of $441MM in 98 different companies, a ratio of 290 to 1 of stock notional sold to bought.
But wait: this is GREAT NEWS: last week the ratio was 650 to 1! So this is a huge improvement and certainly yet another reason for today's rally, even though last week total notional sold was $332 million, or just under 25% lower, and sellers came in well lower at "just" 72.
But who needs details when you have the Fed... Certain not retail, which has now pulled money out of domestic stock funds for 19 straight weeks. So for those wondering just who is orchestrating today's move higher, please let us know if you find out.
Insider Selling Outpaces Buying By Over 290-To-1 In Past Week | zero hedge
According to Bloomberg, for the week ended September 17, corporate insiders bought $1.4MM in shares in a whopping 7 different companies. This was just marginally offset by sales of $441MM in 98 different companies, a ratio of 290 to 1 of stock notional sold to bought.
But wait: this is GREAT NEWS: last week the ratio was 650 to 1! So this is a huge improvement and certainly yet another reason for today's rally, even though last week total notional sold was $332 million, or just under 25% lower, and sellers came in well lower at "just" 72.
But who needs details when you have the Fed... Certain not retail, which has now pulled money out of domestic stock funds for 19 straight weeks. So for those wondering just who is orchestrating today's move higher, please let us know if you find out.
rafaxl
Guest
Tocado, estamos en 72.
:rafaxl
Guest
Si pero lo curioso es que ha tocado el 882 (creo) y ha vuelto abajo un poco. A ver que dice el capitan barbagris.
carvil
Madmaxista
- Desde
- 11 Dic 2008
- Mensajes
- 6.953
- Reputación
- 14.104
Buenos dias 
Soporte actual en el E-Mini 1133 resistencia zona de 1144
Salu2
Soporte actual en el E-Mini 1133 resistencia zona de 1144
Salu2
Interesado
Madmaxista
Para el que le pueda interesar, dejo un par de gráficos con la evolución del ratio de Puts/Calls sobre índices desde 2008 y desde 2010.
Será que estoy espeso, pero a parte del spike de hace unos días dónde se cansaron de comprar puts, todo parece indicar que seguiremos lateral-alcistas.
Por cierto, podríamos estar dibujando uno de estos...
Será que estoy espeso, pero a parte del spike de hace unos días dónde se cansaron de comprar puts, todo parece indicar que seguiremos lateral-alcistas.
Por cierto, podríamos estar dibujando uno de estos...
Última edición:
rafaxl
Guest
Vamonosss!!!!!!! "buen" dato de viviendas de los yankis. A ver donde paramos o que maniobra tienen preparada.
pecata minuta
Madmaxista
- Desde
- 5 Ago 2008
- Mensajes
- 4.372
- Reputación
- 3.778
Andale, andale, arriba, arriba.
pollastre
Madmaxista
- Desde
- 18 Ene 2010
- Mensajes
- 5.407
- Reputación
- 8.200
rafaxl
Guest
Ya se que no justifica nada pero bueno otro dato bueno el de ventas redbook ese. +2,2%.
El crudo brent acercandose peligrosamente a los 80 dolares.
Buenas tardes.
El crudo brent acercandose peligrosamente a los 80 dolares.
Buenas tardes.
Interesado
Madmaxista
A mi me sale que estamos todavía dentro del canal, ha sido una rotura mínima.
Ojo con la euforia que han habido ventas en la última subida. Quirópteros al acecho.
Con Tito Ben al acecho, nadie está a salvo.
Ojo con la euforia que han habido ventas en la última subida. Quirópteros al acecho.
Con Tito Ben al acecho, nadie está a salvo.
Malus
Madmaxista
- Desde
- 23 Jun 2010
- Mensajes
- 200
- Reputación
- 125
Hola DonPepito, Hace unos dias decias que NVAX podria estar interesante para entrar en los 2.20(ahora mismo esta en ellos), que objetivos de precio le das a este valor?
donpepito
Madmaxista
NVAX, están cerrando cortos... los animos están por los suelos... veo una señal de compra, pero está sumamente manipulada.
Yo estoy dentro.... obj a corto los 2.51 USD.
UBS está entre los MMs que juegan con los largos.
Yo estoy dentro.... obj a corto los 2.51 USD.
UBS está entre los MMs que juegan con los largos.
Última edición: